ServiziMenu principaleHome
You are here: Home > What we do > Past events > 2015 > 8th ESO-EONS Masterclass in Oncology Nursing
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

8th ESO-EONS Masterclass in Oncology Nursing

Not eligible for ESCO credits

07.03.2015  -  12.03.2015

Ermatingen, Switzerland




Chairs: A. Margulies, CH - L. Sharp, SE
Scientific Co-ordinator: B. Grube, DK

The Masterclass in Oncology Nursing programme is designed for European advanced oncology nurses as a multi-professional joint event. Five intensive days of full immersion in up-to-date oncology will create a collective spirit of teaching and learning to improving clinical skills and patient care.

Nursing sessions are specific nursing-oriented sessions exploring specialist practice skills such as assessment and decision making, communication skills, complex symptom management, research in nursing, psychosocial consequences of cancer therapy to mention a few.
Other sessions will provide the forum for reviewing and understanding the growing evidence base for nursing interventions and reflect on participant’s role in clinical leadership. Case studies will be presented by the participants and will explore nursing practice focusing on special aspects of care.

In joint clinical sessions, nurses will, together with physicians, update their clinical knowledge about the latest issues for the management of various cancers, with an international faculty of experts. Special joint sessions will highlight and support the growing need for multidisciplinarity in chosen topics.

Practical training will be offered in smaller group optional sessions and coaching groups focusing on skills required for the management of active therapy and follow up.

The Masterclass aims to prepare oncology nurses for future senior roles and enhance their clinical knowledge in the management of the cancer patient during all phases of the cancer journey. Following completion of the course nurses will be able to use evidence based knowledge in effective symptom management and interventions with the aim to improve patient experience, symptom management and care.

Learning outcomes:

• Understand new developments in oncology disease management.
• Recognise and describe acute and late adverse effects of cancer and its treatment.
• Identify complex patient needs across the diagnostic and oncology treatment trajectory.
• Demonstrate communication skills in managing oncology nursing care.
• Critically appraise the evidence for cancer symptom management and intervention.
• Describe the role of the advanced oncology nurse in leading clinical nursing care.
• Reflect on theoretical underpinnings of decision making

The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will include notes and resources. Participants will be supported within small groups and discuss personal development plans with tutors in the faculty. Skills based clinical sessions will be interactive and participants must be prepared to join in.

All participants will reside at the course venue and participation in the nursing sessions is compulsory throughout the course.
The Masterclass will be entirely in English and fluency in English is necessary for admission.
Participants of the Masterclass in Nursing Oncology will attend selected medical sessions. Clinical case studies, submitted prior to the course, will be a requirement for all participants. The faculty will evaluate which case studies will be presented for group discussion.

• A 5-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering advanced concepts


General information

European Oncology Nursing Society, EONS Secretariat
Att. Rudi Brike
c/o Haysmacintyre
26 Red Lion Square,
London, WC1R 4AG
United Kingdom
Phone +32 2 779 9923

The Masterclass programme will be accredited by the European Oncology Nursing Society.

Faculty list

A. Arber, University of Surrey, Faculty of Health and Medical Sciences, Guildford, UK   
J. Bernier, Genolier Swiss Medical Network, Dept. of Radio-Oncology, Genolier, CH
A. Cervantes, Hospital Clinico Universitario de Valencia, Haematology and Medical Dept., Valencia, ES
A. Costa, European School of Oncology, Scientific Director Office, Milano, IT
G. Curigliano, European Institute of Oncology, Early Drug Development for Innovative therapies division, Milano, IT
T. Eisen, University of Cambridge, Dept. of Oncology, Cambridge, UK
C. Faivre-Finn, The Christie NHS Foundation Trust, Dept. of Clinical Oncology, Manchester, UK
K. Fizazi, Institut Gustave Roussy, Dept. of Cancer Medicine, Villejuif, FR
W. Gatzemeier, Humanitas Cancer Center, Breast Unit, Rozzano, IT
B. Grube, Danish Nurses Organisation, Depf. of Education for Advanced Cancer Nurses, Copenhagen, DK
S. Hillinger, University Hospital Zurich, Dept. of Thoracic Surgery, Zurich, CH
A. Horwich, The Royal Marsden Hospital - Institute of Cancer Research, Dept. of Clinical Oncology, Sutton, UK
A. Hoy, Consultant in Palliative Medicine, Lead for Advanced Communication Skills SWSH, Esher, Surrey, UK
R. Huddart, The Institute of Cancer Research (ICR) - Royal Marsden Hospital, Division of Radiotherapy and Imaging, Sutton, Surrey, UK
D. Kelly, Cardiff University, School of Healthcare Sciences, Cardiff, UK
J.M. Lüthi, Spital STS AG Thun, Onkologiezentrum Thun-Berner Oberland, Thun, CH
A. Margulies, Clinical Oncology Nurse, EONS Executive Board, Zurich, CH
O. Pagani, Oncology Institute of Southern Switzerland (IOSI), Breast Unit, Bellinzona, CH   
N. Pavlidis, University Hospital of Ioannina, Div. of Medical Oncology, Ioannina, GR
F.A. Peccatori, Istituto Europeo di Oncologia, Dept. of Fertility and Procreation in Oncology, Milano, IT
R. Popescu, Hirslanden Klinik Aarau, Tumor Center - Dept. of Medical Oncology, Aarau, CH
G. Pruneri, Istituto Europeo di Oncologia, Dept. of Pathology, Milano, IT
D. Sebag-Montefiore, St James' Institute of Oncology - St James' University Hospital, Dept. of Oncology, Leeds, UK
L. Sharp, Regional Cancer Centre, Stockholm-Gotland, Cancer Care Improvement Dpt., Stockholm, SE
R.A. Stahel, University Hospital Zurich, Clinic for Oncology, Zurich, CH
S. Stoll, Universitäts Spital Zürich , Clinic for Oncology, Zurich, CH
E. Van Cutsem, University Hospital Gasthuisberg, Digestive Oncology Dpt., Leuven, BE
E. van Muilekom, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Urology Dpt., Amsterdam, NL
M. Wells, University of Stirling, NMAHP Research Unit, Stirling, UK



7 March


Participants' arrival, airport transfers, registration

 12:30 Lunch      
 13:45 Focus on ESO, ESMO and EONS
A. Costa, IT - R.A. Stahel, CH - A. Margulies, CH


Communication Skills Workshop - Groups A and B
A. Arber, UK - A. Hoy, UK       
Nursing issues - Groups C, D, E, F           
Grube, DK - A. Margulies, CH - L. Sharp, SE

Coffee break
Communication Skills Workshop - Groups C and D
A. Arber, UK - A. Hoy, UK

Nursing issues - Groups A, B, E, F           
Grube, DK - A. Margulies, CH - L. Sharp, SE


Coffee break  
Communication Skills Workshop - Groups E and F
A. Arber, UK - A. Hoy, UK
 17:45 Nursing issues - Groups A, B, C, D           
Grube, DK - A. Margulies, CH - L. Sharp, SE
 19:15 Meet and Greet MON Participants



8 March



 Clinical session Lung cancer and mesothelioma I   
Chair: Rolf A. Stahel
  • Surgery   
    S. Hillinger, CH
  • Radiotherapy   
    C. Faivre-Finn, UK
  • NSCLC systemic therapy    
    R.A. Stahel, CH
  • Discussion


 Coffee break  



Clinical session Lung cancer and mesothelioma II   
Chair: Rolf A. Stahel


  • Small cell lung cancer   
    C. Faivre-Finn, UK
  • Mesothelioma   
    R.A. Stahel, CH
  • Discussion    
Case stadies 1 
L. Sharp, SE
Radiotherapy principles and new methods       
L. Sharp, SE          
Targeted therapies                   
A. Margulies, CH   
Coffee break
Spotlight session Fertility preservation / Cancer and pregnancy   
F.A. Peccatori, IT      
Spotlight session Physical Activity / Exercise and Cancer   
J.M. Lüthi, CH
 19:30 Dinner 


9 March

8:30 Clinical session Genito-urinary cancers I   
Chair: A. Horwich, UK
  Prostate cancer:    

  • Local therapy: Surgery and radiotherapy   
    A. Horwich, UK
  • First- and second-line endocrine therapies   
    A. Horwich, UK
  • Endocrine resistant - refractory   
    K. Fizazi, FR
  • Discussion   
10:00  Coffee break   
10:30 Clinical session Genito-urinary cancers II   
T. Eisen, UK    
  • Treatment of Bladder cancer   
    R. Huddart, UK
  • Renal cancer: Metastatic renal cancer: Evidence-based treatment   
    T. Eisen, UK   
  • Discussion
12:00 Case studies 2    
L. Sharp, SE
13:00 Lunch
 14:00 Cultural differences and care               
E. van Muilekom, NL - B. Grube, DK                   
 Clinical Trials                   
A. Margulies, CH      
 Coffee break
 16:45 Session to be announced
 17:30 Spotlight session Cancer of unknown primary   
N. Pavlidis, GR
 Spotlight session Advanced oncology nursing practice   
D. Kelly, UK


10 March

Clinical session Gastro-intestinal tumours I   
Chair: D. Sebag-Montefiore, UK       

Colon cancer essentials:    
  • Adjuvant and neoadjuvant treatment of colorectal cancer   
    E. van Cutsem, BE
  • Systemic treatment in advanced disease (including liver)
    E. van Cutsem, BE   
  • Discussion
Coffee break
Clinical session Gastro-intestinal tumours II   
Chair: A. Cervantes, ES

  • Management of rectal cancer (surgery and radiotherapy)   
    D. Sebag-Montefiore, UK   
  • Systemic treatment in early and advanced gastric cancer   
    A. Cervantes, ES  
  • Pancreatic Cancer   
    R. Popescu, CH   
  • Discussion
Case studies 3    
L. Sharp, SE

Market Place
Faculty and participants
Free time

Special evening    


11 March

Clinical session Breast cancer I   
Chair: G. Curigliano, IT    

  • (Neo)Adjuvant chemotherapy and biological agents    
    G. Curigliano, IT   
  • (Neo)Adjuvant endocrine therapy    
    O. Pagani, CH   
  • What the clinician needs to know about breast pathology    
    G. Pruneri, IT   
  • Current controversies and challenges in breast surgery  
    W. Gatzemeier, IT   
  • Discussion  
Coffee break
Clinical session Breast cancer II   
Chair: O. Pagani, CH        

  • Management of HER-2+ and triple negative advanced breast cancer    
    G. Curigliano, IT   
  • Management of ER+ advanced breast cancer    
    O. Pagani, CH   
  • Standards and new techniques in breast radiotherapy   
    J. Bernier, CH   
  • Discussion
Case studies 4    
L. Sharp, SE

Research publications - reading and interpreting     
M. Wells, UK - D. Kelly, UK      
Problem based learning - How to ask the right questions   
B. Grube, DK - E. van Muilekom, NL
Coffee break   

Teenage/Adolescence Cancer           
D. Kelly, UK



12 March

 8:30 Learning assessment test          

Session to be announced

 Coffee break

Wrap-up and evaluation
Faculty and participants

 11:15 Spotlight session Genetics/Genetic counselling   
S. Stoll, CH
 12:00 Closing remarks